Price target
21.820.000.00%
The 19 analysts offering 1 year price forecasts for DR6 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 20 analysts giving stock ratings to DR6 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DR6 EPS for the last quarter is 0.17 CHF despite the estimation of 0.12 CHF. In the next quarter EPS is expected to reach 0.19 CHF. Track more of ACADIA PHARMACEUT financials and stay on top of what is up with the company.
In the next quarter ACADIA PHARMACEUT revenue is expected to reach 244.69 M CHF. Check out ACADIA PHARMACEUT revenue and earnings and make informed decisions.
According to analysts, DR6 price target is 21.82 CHF with a max estimate of 34.73 CHF and a min estimate of 9.80 CHF. Check if this forecast comes true in a year, meanwhile watch ACADIA PHARMACEUT stock price chart and keep track of the current situation with DR6 news and stock market news.
We've gathered opinions of 20 analysts rating DR6 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.